Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Axonics Inc (AXNX)

Axonics Inc (AXNX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,409,894
  • Shares Outstanding, K 47,111
  • Annual Sales, $ 180,290 K
  • Annual Income, $ -80,070 K
  • 60-Month Beta 0.46
  • Price/Sales 18.31
  • Price/Cash Flow N/A
  • Price/Book 7.54
Trade AXNX with:

Options Overview Details

View History
  • Implied Volatility 42.63% ( -5.14%)
  • Historical Volatility 41.44%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 93.79% on 02/16/22
  • IV Low 42.63% on 08/12/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 103
  • Volume Avg (30-Day) 87
  • Put/Call OI Ratio 0.18
  • Today's Open Interest 1,755
  • Open Int (30-Day) 1,574

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.47
  • Number of Estimates 4
  • High Estimate -0.39
  • Low Estimate -0.52
  • Prior Year -0.38
  • Growth Rate Est. (year over year) -23.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
59.89 +20.85%
on 07/13/22
72.65 -0.37%
on 08/08/22
+11.13 (+18.17%)
since 07/12/22
3-Month
44.98 +60.92%
on 05/13/22
72.65 -0.37%
on 08/08/22
+28.11 (+63.50%)
since 05/12/22
52-Week
38.41 +88.44%
on 05/09/22
79.81 -9.31%
on 09/09/21
+7.04 (+10.77%)
since 08/12/21

Most Recent Stories

More News
Here's Why Axonics Modulation Technologies (AXNX) is a Great Momentum Stock to Buy

Does Axonics Modulation Technologies (AXNX) have what it takes to be a top stock pick for momentum investors? Let's find out.

AXNX : 72.38 (+3.28%)
Axonics® Announces Closing of Public Stock Offering and Full Exercise of Underwriter’s Option to Purchase Additional Stock

Axonics, Inc. (Nasdaq: AXNX) (“Axonics”), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced...

AXNX : 72.38 (+3.28%)
Is Axonics (AXNX) Stock Outpacing Its Medical Peers This Year?

Here is how Axonics Modulation Technologies (AXNX) and Dynavax Technologies (DVAX) have performed compared to their sector so far this year.

AXNX : 72.38 (+3.28%)
DVAX : 16.34 (-2.10%)
Axonics® Announces Pricing of Public Offering of Common Stock

Axonics, Inc. (Nasdaq: AXNX) (“Axonics”), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced...

AXNX : 72.38 (+3.28%)
Axonics® Announces Proposed Public Offering of Common Stock

Axonics, Inc. (Nasdaq: AXNX) (“Axonics”), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced...

AXNX : 72.38 (+3.28%)
Axonics Modulation Technologies (AXNX) Reports Q2 Loss, Tops Revenue Estimates

Axonics (AXNX) delivered earnings and revenue surprises of 17.54% and 16.48%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

AXNX : 72.38 (+3.28%)
TALK : 1.6400 (+3.80%)
Axonics® Reports Second Quarter 2022 Financial Results

Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported financial results...

AXNX : 72.38 (+3.28%)
Is Axonics (AXNX) Outperforming Other Medical Stocks This Year?

Here is how Axonics Modulation Technologies (AXNX) and DBV Technologies S.A. (DBVT) have performed compared to their sector so far this year.

AXNX : 72.38 (+3.28%)
DBVT : 2.64 (-1.12%)
Axonics® to Report Second Quarter 2022 Financial Results on August 1

Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, will report second quarter 2022...

AXNX : 72.38 (+3.28%)
Has Axonics (AXNX) Outpaced Other Medical Stocks This Year?

Here is how Axonics Modulation Technologies (AXNX) and Bellus Health (BLU) have performed compared to their sector so far this year.

AXNX : 72.38 (+3.28%)
BLU : 11.80 (+3.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Axonics Modulation Technologies Inc. is focused on development and commercialization of a novel implantable SNM system for patients with urinary and bowel dysfunction and disrupting the SNM market. Axonics Modulation Technologies Inc. is based in Irvine, CA.

See More

Key Turning Points

3rd Resistance Point 76.67
2nd Resistance Point 74.57
1st Resistance Point 73.48
Last Price 72.38
1st Support Level 70.29
2nd Support Level 68.19
3rd Support Level 67.10

See More

52-Week High 79.81
Last Price 72.38
Fibonacci 61.8% 64.00
Fibonacci 50% 59.11
Fibonacci 38.2% 54.22
52-Week Low 38.41

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar